ONCAlert | AstraZeneca: Pioneers in Ovarian Cancer

Current and Emerging Immunotherapeutic Strategies in Melanoma

Omid Hamid, MD
Published Online: 5:01 PM, Fri November 11, 2016


Omid Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, discusses current and emerging immunotherapeutic strategies in the field of melanoma during an interview at the 34th Annual Chemotherapy Foundation SymposiumTM.

Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.